By Benjamin Chiou
Date: Thursday 25 Apr 2024
(Sharecast News) - Pharmaceuticals group Hikma said it has made a "strong and encouraging start" to 2024, with all three business segments performing well, as it held on to guidance for the year.
In a trading update on Thursday, the company's chief executive Riad Mishlawi hailed "continued growth and momentum across...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news